Clinical trial
Single Center Prospective Controlled Follow-up Study of COVID-19 Patients in the District Konstanz (FSC19-KN)
NCT04724434 is registered in ClinicalTrials.gov with Hegau-Bodensee-Klinikum Singen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Center Prospective Controlled Follow-up Study of COVID-19 Patients in the District Konstanz (FSC19-KN)
- Lead sponsor
- Hegau-Bodensee-Klinikum Singen
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 4, 2020
- Completion date
- December 31, 2024
- Enrollment
- 526 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sars-cov-2 positive patients